1. International Agency for Research on Cancer, WHO, GLOBOCAN: cancer today; mortality. https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=cancer&mode_population=continents&population=900&populations=900&key=total&sex=0&cancer=39&type=1&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=15&group_cancer=1&include_nmsc=1&include_nmsc_other=1&half_pie=0&donut=0. (Accessed October 12, 2021).
2. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Lung and bronchus: SEER 5-year age-adjusted incidence rates, 2015-2019. https://seer.cancer.gov/explorer/application.html?site=47&data_type=1&graph_type=10&compareBy=subtype&chk_subtype_47=47&chk_subtype_612=612&chk_subtype_613=613&chk_subtype_611=611&chk_subtype_610=610&series=stage&chk_stage_101=101&chk_stage_104=104&chk_stage_105=105&chk_stage_106=106&chk_stage_107=107&sex=1&race=1&age_range=1&advopt_precision=1. (Accessed October 12, 2021).
3. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. Lung and bronchus: SEER 5-year relative survival rates, 2012-2018. https://seer.cancer.gov/explorer/application.html?site=47&data_type=4&graph_type=5&compareBy=subtype&chk_subtype_47=47&chk_subtype_612=612&chk_subtype_613=613&chk_subtype_611=611&chk_subtype_610=610&series=stage&chk_stage_101=101&chk_stage_104=104&chk_stage_105=105&chk_stage_106=106&chk_stage_107=107&sex=1&race=1&age_range=1&advopt_precision=1. (Accessed October 12, 2021).
4. Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion;Chu;Ther. Adv. Med. Oncol.,2020
5. Current landscape of non-small cell lung cancer: epidemiology, histological classification, targeted therapies, and immunotherapy;Rodak;Cancers (Basel),2021